Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Online resources offer a wealth of information for investment research. Learn how to leverage these tools to improve your investment approach.
21,367 articlesPfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
A rare public reversal from Elon Musk shines a light on Anthropic as a leading AI player. For Amazon and Alphabet inv...
Sam Altman cautions that some companies are blaming AI for layoffs that were planned for other reasons, a trend with ...
As accel acel 2025 earnings loom, investors seek clarity on revenue, margins, and guidance. This guide breaks down wh...
What could Nvidia stock be worth in two years? This article lays out a grounded forecast based on AI demand, data cen...
A single market signal suggests SpaceX's IPO could roar, but history warns investors not to blindly chase headlines. ...
Investors are watching Bionano Genomics as the company enters 2026 with evolving demand for optical genome mapping. T...
An Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...
Palantir stock down this year has rattled investors. This guide breaks down the fundamentals, what the pullback means...
On Tuesday morning, Lockheed Martin stock dropped sharply before trimming losses. This deep dive explains the mix of ...
A big investment firm has exited its complete stake in a biotech company, disclosed in an SEC filing. The move provid...
South Korea's possible investment in NuScale Power's SMR program could shift the nuclear landscape and offer new oppo...